Endoscopy 2015; 47(06): 538-540
DOI: 10.1055/s-0034-1391395
Case series
© Georg Thieme Verlag KG Stuttgart · New York

Gastric antral vascular ectasia: a prospective study of treatment with endoscopic band ligation

Sergio Zepeda-Gómez
1   Division of Gastroenterology, University of Alberta Hospital, Edmonton, Alberta, Canada
,
Richard Sultanian
1   Division of Gastroenterology, University of Alberta Hospital, Edmonton, Alberta, Canada
,
Christopher Teshima
1   Division of Gastroenterology, University of Alberta Hospital, Edmonton, Alberta, Canada
,
Gurpal Sandha
1   Division of Gastroenterology, University of Alberta Hospital, Edmonton, Alberta, Canada
,
Sander Van Zanten
1   Division of Gastroenterology, University of Alberta Hospital, Edmonton, Alberta, Canada
,
Aldo J. Montano-Loza
2   Division of Hepatology, University of Alberta Hospital, Edmonton, Alberta, Canada
› Author Affiliations
Further Information

Publication History

submitted 12 November 2014

accepted after revision 07 December 2014

Publication Date:
04 February 2015 (online)

Gastric antral vascular ectasia (GAVE) is characterized by red, angiomatous lesions in the antrum organized either in stripes or in a diffuse pattern that can be associated with upper gastrointestinal bleeding. Endoscopic band ligation (EBL) has been reported as an effective alternative therapy for patients with GAVE. Consecutive patients with a diagnosis of GAVE were prospectively followed while undergoing EBL every 2 months. Hemoglobin, ferritin, and iron levels were frequently recorded, and clinical follow-up was performed. A total of 21 patients with GAVE were enrolled, and 17 of these patients (81 %) had associated co-morbidities, most frequently cirrhosis and chronic renal failure. A clinical response was achieved in 19 patients (91 %). A significant improvement in the mean hemoglobin level was noted after EBL (P < 0.001), and a significant decrease in blood transfusion requirements per month (P = 0.001). No major complications were observed during the study period. The mean follow-up was 10 months. EBL is an effective and safe treatment for GAVE. Randomized, controlled trials comparing EBL with other endoscopic therapies are warranted.

 
  • References

  • 1 Regula J, Wronska E, Pachlewski J. Vascular lesions of the gastrointestinal tract. Best Pract Res Clin Gastroenterol 2008; 22: 313-328
  • 2 Ito M, Uchida Y, Kamano S et al. Clinical comparisons between two subsets of gastric antral vascular ectasia. Gastrointest Endosc 2001; 53: 764-770
  • 3 Ripoll C, Garcia-Tsao G. Management of gastropathy and gastric vascular ectasia in portal hypertension. Clin Liver Dis 2010; 14: 281-295
  • 4 Swanson E, Mahgoub A, MacDonald R et al. Medical and endoscopic therapies for angiodysplasia and gastric antral vascular ectasia: a systematic review. Clin Gastroenterol Hepatol 2014; 4: 571-582
  • 5 Sato T, Yamazaki K, Akaike J. Endoscopic band ligation versus argon plasma coagulation for gastric antral vascular ectasia associated with liver diseases. Dig Endosc 2012; 24: 237-242
  • 6 Wells CD, Harrison ME, Gurudu SR et al. Treatment of gastric antral vascular ectasia (watermelon stomach) with endoscopic band ligation. Gastrointest Endosc 2008; 68: 231-236
  • 7 Keohane J, Berro W, Harewood GC et al. Band ligation of gastric antral vascular ectasia is a safe and effective endoscopic treatment. Dig Endosc 2013; 25: 392-396
  • 8 Gross SA, Al-Haddad M, Gill KR et al. Endoscopic mucosal ablation for the treatment of gastric antral vascular ectasia with the HALO90 system: a pilot study. Gastrointest Endosc 2008; 67: 324-327
  • 9 Dray X, Repici A, Gonzalez P et al. Radiofrequency ablation for the treatment of gastric antral vascular ectasia. Endoscopy 2014; 46: 963-969